Breathable Film Market demand is expected to grow at a CAGR of 5.6% from 2016 to 2024

Global Breathable Film Market is expected to reach USD 22.83 billion by 2024 according to a new report by Grand View Research, Inc. The growing demand for breathable films in the packaging, healthcare, hygiene, and apparel industry is anticipated to drive market demand over the coming years. 

The breathable film market is strongly influenced by new product developments and expansions into emerging markets. The increasing use of breathable films in hygiene and building & construction market is anticipated to boost the market growth in Asia Pacific. Stringent regulations concerning use of protective apparel in the healthcare and industrial sector are expected to augment future market growth. 

Rising demand for waterproof garments in sports apparels is projected to propel the demand for breathable films over the forecast period. Increasing investments in the healthcare sector is expected to drive the demand for masks, gloves, drapes, sheets, and other disposable garments over the coming years.

Access for full detail of report: http://www.grandviewresearch.com/industry-analysis/breathable-film-market

Further key findings from the report suggest:

• The global breathable film market demand was 5.48 million tons in 2015 and is expected to reach 8.92 million tons by 2024, growing at a CAGR of 5.6% from 2016 to 2024
• Polyester dominated the breathable film market in 2015 accounting for around 33% of the global market demand in the raw material segment. It is also expected to witness the highest growth of 6.0% over the forecast period.
• Non-porous films were the leading product segment and accounted for over 70% of global demand in 2015. Increasing penetration for healthcare and food packaging application is expected to drive this segment over the forecast period.
• The packaging segment occupied the largest share in 2015, on account of growing demand for breathable films in the convenience food, confectionery & bakery products, meat, and processed food market.
• Asia Pacific is anticipated to witness a significant growth over the forecast period on account of the growing building & construction and manufacturing sector
• The increasing demand for protective apparel in the medical and industrial sector of North America and Europe is anticipated to boost future market growth in this region.
• Major companies identified in the market include Argotec LLC., Arkema, Clopay Plastics, Fatra, a.s., Kimberley-Clark, and Nitto Denko Corporation among others. 

Borrows Related report from same Category: http://www.grandviewresearch.com/industry/specialty-and-fine-chemicals 

Grand View Research has segmented the breathable film market on the basis of raw material, product, application, and region:

Global Breathable Films Raw Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Polyester
• Polyethylene
• Polypropylene
• Others

Global Breathable Films Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Microporous
• Microvoid
• Non-porous

Global Breathable Films Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Hygiene
• Healthcare
• Building & Construction
• Industrial Protective Apparels
• Packaging
• Sports Apparels
• Others

Global Breathable Films Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
North America

• U.S.

Europe

• Germany
• UK
• France

Asia Pacific

• China
• India
• Japan
• Malaysia
• Indonesia
• Thailand

Central & South America

• Brazil

Middle East & Africa

• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-breathable-film-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Breast Imaging Market Quantitative Analysis by Market Size, Estimates, and Forecast from 2013 to 2024

Global Breast Imaging Market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the study suggest:

• The 3D tomo synthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.
• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

Borrows all related Reports from same Category: http://www.grandviewresearch.com/industry/medical-imaging  

Grand View Research has segmented Breast Imaging market on the basis of technology and region.

Global Breast Imaging Market Technology Outlook (Revenue, USD Million, 2013 – 2024)

• Ionizing technology
  • Full-Field Digital Mammography
  • Analog Mammography
  • Positron Emission Mammography
  • Electrical Impedance Tomography
  • Cone Beam Computed Tomography
  • Positron Emission Tomography & Computed Tomography
  • 3D Breast Tomosynthesis
• Molecular breast imaging/breast-specific gamma imaging (MBI/BSGI)
• Non-ionizing technology
• Breast MRI
• Breast Thermography
• Breast Ultrasound
• Optical Imaging
• Automated Whole-Breast Ultrasound

Breast Imaging Market Regional Outlook (Revenue, USD Million, 2013 – 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany

Asia Pacific

• Japan
• China

Latin America

• Brazil
• Argentina

MEA

• South Africa
• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-breast-imaging-equipment  
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Blood Screening Market Variables, Trends and Scope 2013-2024

Global Blood Screening Market is expected to reach a value of USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing screening of donor and continuous technological advancements by the market players. Demand for blood screening tests are increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). Result of all these assays must be negative for blood donation.

Technological developments in the market increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/blood-screening-market

Further Key Findings from the Study Suggest:

• Nucleic acid amplification test or nucleic acid test (NAT) is expected to be the fastest growing segment during the forecast period. It comprises transcription mediated amplification (TMA) tests and polymerase chain reaction. Increasing demand of NAT over ELISA test due to high sensitivity and specificity for viral nucleic acid is contributing to the fastest growth during the forecast period.
• In 2015, reagent dominated the product segment. Introduction of new assays for the detection of various diseases is expected to enable the segment to gain the maximum share of market in the coming years. For instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS TaqScreen MPX Test for the detection and identification of HCV, HIV, and HBV. 
• In 2015, regionally North America dominated with a revenue share of more than 40%. Government initiatives, presence of major players, and more patient affordability are the major factors that contributed toward its dominance.
• In August 2016, the FDA recommended the testing of all the donated blood in the U.S. and its territories for Zika virus in order to prevent transmission of this virus through the blood supply.
• Asia Pacific is expected to be the fastest growing region due to increasing investment of industry players, government initiatives, and rising awareness about transmission of diseases during its transfusion.
• The Red Cross in Japan entered into a contract with Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan in 2014. This agreement is anticipated to propel the NAT market during the forecast period. However, low donation as compared to requirement and high cost of kits and instruments are likely to restrain the growth in low-income countries during the forecast period.

Borrows all related reports from same Category: http://www.grandviewresearch.com/industry/clinical-diagnostics 

Grand View Research has segmented the blood screening market by technology, product and region:

Blood Screening Market Technology Outlook (Market Revenue in USD Million, 2013 - 2024)

• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next-Generation Sequencing (NGS)
• Western Blotting

Blood Screening Market Product Outlook (Market Revenue in USD Million, 2013 - 2024) 

• Reagent
• Instrument

Blood Screening Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany

Asia Pacific

• Japan
• China

Latin America

• Brazil

Middle East and Africa

• South Africa

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-blood-screening-market   
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Blockchain Technology Market report forecasts revenue growth at global, regional & country levels and provides an analysis on the Industry Trends from 2015 to 2024

Global Blockchain Technology Market is expected to reach USD 7.74 billion by 2024, according to a new report by Grand View Research, Inc. Blockchain is the underlying technology that originated in the form of a public ledger to keep a track of all cryptocurrency transactions. The technology works as an electronic transaction-processing and record-keeping system. This allows various participants that are connected to the network, usually public, to track information through a secure network, thereby eliminating the need for any kind of third-party verification.

The increasing adoption of the technology in the financial services sector and expected adoption across the public sector and healthcare segments are few of the major factors that are expected to fuel the demand for the said market.
The market is expected to grow rapidly owing to numerous benefits that it provides, such as eradication of the requirement of a financial institution to validate transactions, reduce duplicative record keeping, eliminate reconciliation, minimize error rates, and facilitate faster settlement. With the use of the said technology, the databases could become universal in nature, thereby allowing multiple institutions to use it at the same time to bring various different systems closer together and help increase the efficiency.
The increasing demand for this technology across financial services, consumer or industrial products, technology, media & telecom, healthcare, transportation, and public sector is largely responsible for driving the market toward growth.

The major drivers include the growing interest of the BFSI sector and increasing merchants accepting crypto currencies among others. The probable opportunity of this technology further includes the instant settlement of various financial transactions and achieving optimized settlement options for the netting and clearing process.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/blockchain-technology-market

Further key findings from the report suggest:

• Recently, investments have been made in the technology by various financial institutions in association with key technology players to further improve the efficiency of the underlying financial processes and help minimize the risk
• The technology will be able to support IoT applications, book keeping in the healthcare sector, instantaneous payments in the transportation segment, and maintenance of records for land ownership by the governments in the public sector.
• Some of the prominent vendors in the market include Chain Inc., Circle Internet Financial Limited, Digital Asset Holdings, Eric Industries, IBM Corporation, Linux Foundation, Post-Trade Distributed Ledger, R3, Ripple, and Safello.

Borrows all related Reports from same Category: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies 

Grand View Research has segmented the blockchain technology market has been segmented on the basis of type, application, and region:

Blockchain Technology Type Outlook (Revenue, USD Million; 2015 - 2024)

• Public
• Private
• Hybrid

Blockchain Technology Application Outlook (Revenue, USD Million; 2015 - 2024)

• Financial Services
• Consumer orIndustrial Products
• Technology, Media, and Telecom
• Healthcare
• Transportation
• Public Sector

Blockchain Technology Regional Outlook (Revenue, USD Million; 2015 - 2024)

• North America
• Europe
• Asia Pacific
• Rest of the World

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-blockchain-technology-market  
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Biomarkers Market Competitive Landscape by Strategic Framework and Market Participation Categorization

Global Biomarkers Market is expected to reach over USD 78.2 billion by 2024, according to a new report by Grand View Research, Inc. The growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the growth of the biomarkers market. The increasing need of disease-specific biomarkers for the development of diagnostics, the increasing R&D funding, and the rising prevalence of oncology and cardiovascular-based diseases are anticipated to create significant opportunities for the market growth during the forecast period.

The spiralling population and the upward trend in the adoption of sedentary lifestyles are expected to provide the industry with a huge target population base. Government grants and research funding for the discovery and development of novel biomarkers are the other factors accentuating the market growth. The introduction of the biomarker-based diagnostic kits for screening high-risk population coupled with the growing prevalence of genetic disorders is also anticipated to increase the client base for this market.

Access for full Detail of the Report: http://www.grandviewresearch.com/industry-analysis/biomarkers-industry

Further key findings from the study suggest:

• The safety biomarkers segment held the largest share of over 40% in 2015 owing to the increasing routine healthcare check-ups and the growing base of the geriatric population that is at a high risk of developing various diseases
• The validation biomarkers segment is determined as one of the fastest growing segments. The increasing R&D initiatives for the development of more specific biomarkers, and hence the subsequent development of companion diagnostics with enhanced accuracy and sensitivity for the effective detection of diseases are key factors contributing towards the aforementioned growth.
• The drug discovery segment dominated the application segment in 2015. Biomarkers are extensively used by pharmaceutical companies to accelerate the development of new drug findings and to predict the failure of the upcoming drugs.
• The diagnostic segment is estimated to witness a lucrative growth over the forecast period owing to the growing awareness about routine healthcare check-ups and the rising prevalence of various diseases
• In 2015, the oncology segment dominated with a revenue generated over USD 9.2 billion owing to the introduction of companion diagnostic tests for oncology drugs and the growing burden of cancer across the globe
• The cardiovascular segment is expected to be the fastest growing segment with a CAGR of over 14.0%. The growing adoption of sedentary lifestyles and the rise in the obese population base leading to cardiovascular diseases are estimated to provide this market with a potential growth platform.
• North America held the largest regional share of around 39% in 2015. The well-established R&D infrastructure and the high level of disposable income are the factors contributing towards the large market share.
• Asia Pacific is anticipated to be the fastest growing biomarker market owing to the factors, such as the developing economic conditions, a large base of the target population, and a favourable regulatory scenario for clinical trials.
• Major players include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson and Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen, Inc., Merck& Co., Inc., and others
• Market participants are ensuring stability by funding the growing R&D initiatives and focusing on the developing countries through the expansion and introduction of novel biomarker diagnostics. In 2015, Pfizer, Inc. developed a lung cancer therapy drug, Crizotinib used in non-small cell lung cancer therapy associated with ALK fusions.

Borrows all Related reports from same Category: http://www.grandviewresearch.com/industry/biotechnology 

Grand View Research has segmented the global biomarkers market on the basis of application, type, and region:

Global Biomarkers Type Outlook (Revenue, USD Million, 2014 - 2024)

• Safety
• Efficacy
• Validation

Global Biomarkers Application Outlook (Revenue, USD Million, 2014 - 2024)

• Diagnostic
• Drug Development 
•  Personalized Medicine
• Others

Global Biomarkers Disease Outlook (Revenue, USD Million, 2014 - 2024)

• Oncology
• Cardiovascular disease
• Neurological disease
• Immunological disease
• Others

Biomarkers Regional Outlook (Revenue, USD Million, 2014 - 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Spain
• Italy

Asia Pacific

• Japan
• China
• India

Latin America

• Brazil
• Mexico

MEA

• South Africa

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-biomarkers-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com
 

Radiation Dose Monitoring Market Variables, Trends and Scope 2014-2025

Global Radiation Dose Monitoring Market is anticipated to reach a value of USD 3.9 billion by 2025, according to a new report by Grand View Research, Inc. The advantage of automated dose monitoring systems to track individual and cumulative radiation dose exposure in patients is driving significant demand for the product.

Dose monitoring is achieved by the use of software and designated products such as dosimeters. Dose management software analyzes, identifies, and optimizes radiation dose performance with precise data. This data aids the physicians to provide quality care to the patients. Furthermore, easy integration of software into existing medical architecture of hospitals will boost the value of existing medical systems and ensure safety of using them.

Area of application commonly employing the use of medical imaging is radiography, angiography, mammography, fluoroscopy & interventional imaging and nuclear medicine. Several medical imaging technology manufacturers are constantly involving in the incorporation of the radiation dose monitoring tools in these imaging platforms. X-ray and computed tomography technique are known to emit a large amount of radiation as compared to other imaging platforms. The overall market exhibits promising growth prospects pertaining to high prevalence of chronic diseases, effective and reliable treatment methods focusing on care, and increasing patient awareness.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/radiation-dose-monitoring-market

Further key findings from the study suggest:

• North America reported highest revenue growth in this market in 2015. A shift to the value based care delivery model has resulted in healthcare providers to divert their attention to deliver healthcare services concentrating on the well-being of a patient
• Asia Pacific region provides lucrative market opportunities for radiation dose monitoring. Significant factors such as rapid urbanization, upgrade in healthcare infrastructure and delivery will further support the market growth in emerging economies like India and China
• The market for radiation dose monitoring software is expected to generate strong revenue growth in the fiscal year 2015. The software market enables easy integration to existing architecture in healthcare facilities, and will sync into the integrated care delivery benefitting the specialists to provide better and monitored care
• The major market players recognized in this market are GE Healthcare, Sectra, Medicvision, Philips Healthcare, Toshiba MSC, Bayer AG, Landauer, Inc. and Thermo Fisher Scientific, Inc.

View all related reports from same category: http://www.grandviewresearch.com/industry/medical-devices 

Grand View Research has segmented the radiation dose monitoring market by component, application and product:

Component Outlook (Revenue, USD Million; 2014 - 2025)

• Software
• Service

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Radiography
• Angiography
• Mammography
• Fluoroscopy & Interventional Imaging
• Others

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Dosimeters
• Area Process Monitors
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• China
• Japan

Latin America

• Mexico
• Brazil

MEA

• South Africa
• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-radiation-dose-monitoring-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Botulinum Toxin Market Analysis 2013 and Forecast up to 2025

Global Botulinum Toxin (BNT) Market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

Access for the full detail of the Report: http://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market

Further Key Findings from the Study Suggest:

• The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.
• The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period
• In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan
• Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

View all the Related Reports from same Category: http://www.grandviewresearch.com/industry/pharmaceuticals 

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 - 2025)

• Botulinum Toxin Type A
• Botulinum Toxin Type B

End Use Outlook (Revenue, USD Million; 2013 - 2025)

• Therapeutic
• Aesthetic

Regional Outlook (Revenue, USD Million; 2013 - 2025)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• China
• Japan

Latin America

• Mexico
• Brazil

MEA

• South Africa

Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-botulinum-toxin-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com